Clinical Trial Detail

NCT ID NCT02058706
Title LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer
Recruitment Unknown status
Gender male
Phase Phase II
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

prostate adenocarcinoma

Therapies

Goserelin

Bicalutamide

Enzalutamide

Leuprolide

Age Groups: adult

No variant requirements are available.